Skip to main content

Table 4 Survival data in 76 esophageal cancer patients (time in months).

From: High-dose chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer: a retrospective cohort study

 

Surgery

95% CI

CRT + Surgery

95% CI

p

No. of patients

45

 

31

  

Overall survival (median)

11.1

7.63 - 14.53

31.4

11.90-50.98

0.042

Disease-specific survival (median)

11.1

7.63 - 14.53

34.4

6.88-61.91

0.019

Progression free survival (median)

9.5

7.36 - 11.63

18.0

8.48 - 27.52

0.064

DMFS (median)

9.6

6.75 - 12.50

17.94

6.39 - 29.48

0.058

# LR free survival (median)

X

 

X

 

0.67

Patients free of LR after 3 years

69%

 

71%

  

Patients free of LR after 5 years

61%

 

71%

  

1 year overall survival rate

44%

 

68%

  

3 year overall survival rate

24%

 

44%

  

5 year overall survival rate

16%

 

29%

  
  1. Confidence interval. Chemoradiotherapy. Distant metastasis free survival. # Local recurrence. X = not reached. Local recurrence free survival stands for survival from treatment start until disease recurrence in the field of radiotherapy and/or field of surgery in the mediastinum.